##gff-version 3
##sequence-region P20292 1 161
P20292	UniProtKB	Chain	1	161	.	.	.	ID=PRO_0000217751;Note=Arachidonate 5-lipoxygenase-activating protein	
P20292	UniProtKB	Topological domain	1	8	.	.	.	Note=Lumenal;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17600184;Dbxref=PMID:17600184	
P20292	UniProtKB	Transmembrane	9	30	.	.	.	Note=Helical	
P20292	UniProtKB	Topological domain	31	52	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17600184;Dbxref=PMID:17600184	
P20292	UniProtKB	Transmembrane	53	77	.	.	.	Note=Helical	
P20292	UniProtKB	Topological domain	78	80	.	.	.	Note=Lumenal;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17600184;Dbxref=PMID:17600184	
P20292	UniProtKB	Transmembrane	81	102	.	.	.	Note=Helical	
P20292	UniProtKB	Topological domain	103	107	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17600184;Dbxref=PMID:17600184	
P20292	UniProtKB	Intramembrane	108	115	.	.	.	.	
P20292	UniProtKB	Transmembrane	116	128	.	.	.	Note=Helical	
P20292	UniProtKB	Topological domain	129	161	.	.	.	Note=Lumenal;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17600184;Dbxref=PMID:17600184	
P20292	UniProtKB	Region	20	27	.	.	.	Note=Inhibitor binding	
P20292	UniProtKB	Region	112	123	.	.	.	Note=Inhibitor binding	
P20292	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Increased affinity for the inhibitor MK-591. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17600184;Dbxref=PMID:17600184	
P20292	UniProtKB	Mutagenesis	27	27	.	.	.	Note=Strongly decreased affinity for the inhibitor MK-591. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17600184;Dbxref=PMID:17600184	
P20292	UniProtKB	Mutagenesis	30	30	.	.	.	Note=Strongly decreased affinity for the inhibitor MK-591. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17600184;Dbxref=PMID:17600184	
P20292	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Decreased affinity for the inhibitor MK-591. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17600184;Dbxref=PMID:17600184	
P20292	UniProtKB	Mutagenesis	66	66	.	.	.	Note=Strongly decreased affinity for the inhibitor MK-591. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17600184;Dbxref=PMID:17600184	
P20292	UniProtKB	Mutagenesis	112	112	.	.	.	Note=Strongly decreased affinity for the inhibitor MK-591. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17600184;Dbxref=PMID:17600184	
P20292	UniProtKB	Mutagenesis	113	113	.	.	.	Note=Increased affinity for the inhibitor MK-591. I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17600184;Dbxref=PMID:17600184	
P20292	UniProtKB	Mutagenesis	116	116	.	.	.	Note=Strongly increased affinity for the inhibitor MK-591. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17600184;Dbxref=PMID:17600184	
P20292	UniProtKB	Mutagenesis	123	123	.	.	.	Note=Decreased affinity for the inhibitor MK-591. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17600184;Dbxref=PMID:17600184	
P20292	UniProtKB	Sequence conflict	161	161	.	.	.	Note=P->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
